Erythrocytes shed membrane vesicles in response to many stimuli. It has been previously demonstrated that glycan phosphatidylinositol-linked (GPI-linked) proteins such as decay accelerating factor and acetylcholinesterase are concentrated in these vesicles relative to the erythrocyte membrane. W e have examined the requirement for GPIlinked proteins for the process of vesiculation. Erythrocytes that do not express GPI-linked proteins, obtained from patients with paroxysmal nocturnal hemoglobinuria (PNH), release between 10% and 50% of the quantity of vesicles as normal cells in response to the Ca2+ ionophore A231 87. Platelets from the same patients produced 10% to 20% of HE RELEASE of vesicles from cells (shedding) can occur T during the normal turnover on membrane or in response to various stimuli. Erythrocytes shed membrane vesicles in response to heat, Ca2' loading, ATP depletion, and the addition of amphipathic compounds.'-6 Platelets shed membrane vesicles in response to A23 187 or to a combination of thrombin and c~llagen.',~ Membrane insertion of complement components C5b-9 and Ca2+ influx stimulates rapid vesicle shedding in human and guinea pig erythrocytes, platelets, neutrophils, cultured cells, and oligodendrocytes and contributes to the survival of the cells under a t t a~k .~-'~ Neutrophils and oligodendrocytes have been shown to protect themselves from perforin channels by membrane vesiculat i~n . '~. '~ The molecular mechanisms underlying this brisk and functional response are unknown. Our approach to this problem was stimulated by the intriguing observation that proteins anchored to the plasma membrane via glycosylphosphatidylinositol (GPI), such as acetylcholinesterase (AChE) and decay accelerating factor (DAF) (CD55), are greatly enriched in the membranes of calcium-induced erythrocyte vesicle^.'^ This finding, taken together with the growing evidence that GPI-linked molecules are involved in signaling specific cellular responses, raises the possibility that GPI plays a role in triggering the process of vesiculati~n.''-'~ The experiments to be presented here were designed to test this hypothesis. We reasoned that if our hypothesis were to be true, one prediction would be that cells that lack GPI-anchored molecules, such as those from patients with paroxysmal nocturnal hemoglobinuria (PNH), would display a defect in v e s i~u l a t i o n .~~
were to be true, one prediction would be that cells that lack GPI-anchored molecules, such as those from patients with paroxysmal nocturnal hemoglobinuria (PNH), would display a defect in v e s i~u l a t i o n .~~
MATERIALS AND METHODS

Eu@ers and solutions.
All buffers were prepared with glass-distilled water and ultrafiltered before use: phosphate-buffered saline (PBS), 150 mmol/L NaCI, 5 mmol/L sodium phosphate, pH 7.4; dextrose, gelatin, veronal-buffered saline with calcium, magnesium (DGVB2+), veronal-buffered saline containing 7 I mmol/L NaCl and 2.5 mmol/ L sodium veronal, 0.1% gelatin, 0.15 mmol/L CaCI2, 1 mmol/L MgCI2, and 139 mmol/L dextrose; gelatin, veronal-buffered saline with calcium, magnesium (GVB2+), veronal-buffered saline, pH 7.4, containing 142 mmol/L NaC1, 4.9 mmol/L sodium veronal, 0.1% gelatin, 0. I5 mmol/L CaClz, and 1 mmol/L MgCI,; GVBZ-, veronalbuffered saline, pH 7.4, containing 142 mmol/L NaC1, 4.9 mmol/L sodium veronal, and 0.1% gelatin; GVB-EDTA, 9 vol ofGVB2-mixed with 1 vol of 0.1 mol/L EDTA, pH 7.4; Tyrode's buffer, a 20X stock was made containing 2.74 mol/L NaCI, 0.1 I 1 mol/L dextrose, 0.05 mol/L KCI, 0.238 mol/L NaHCO,, 0.2% NaN,. For Tyrode's-EDTA, this 20X stock also contained 0. IO mol/L EDTA. Tyrode's buffer was made by mixing 1 vol of 20X concentrate with 19 vol of water and 0.8 vol of 0.5 mol/L HEPES, pH 7.5. Acetylsalicylic acid (1.8 g/L) was freshly added. Tyrode's-EDTA was made in the same fashion, except the Tyrode's-EDTA 20X stock was used instead of the Tyrode's 20X stock.
The monoclonal antibodies (MoAbs) against DAF, IAIO, and IIH6 were described in Kinoshita et al. 25 The MoAb against CD59, MEM-43, was a generous gift of Dr Irena Stefanova (Czechoslovak Academy of Sciences). Before use, the antibodies were purified from ascites fluid using Affi-gel protein A-Sepharose kit (Calbiochem, San Diego, CA).
Blood from normal controls or PNH patients was collected in tubes containing EDTA. 26 The blood of one patient was a generous gift of Dr Wendell Rosse (Department of Hematology, Duke University Medical Center, Durham, NC). Erythrocytes from PNH patients (108/mL in PBS, 0.1% bovine serum albumin [BSA] , 0.02% azide [PBS-AZ]) were mixed with an equal volume of 5 pg/mL MEM-43, 5 pg/mL of IA10, and 5 pg/mL of IIH6. After incubation for 60 minutes on ice, cells were washed once with PBS-AZ, resuspended at 109/mL, and then loaded into a protein A-Sepharose CL-4B column (2 X 10' erythrocytes/ mL packed gel; Pharmacia, Piscataway, NJ) equilibrated in the same buffer. The column was closed and kept for 15 minutes at room temperature. Unbound cells were collected by washing the column with five column volumes of the same buffer. Blood from either normal volunteers or patients with PNH was collected in EDTA. Erythrocytes were washed, stored in DGVB2+, and used within 3 days of collection. For vesiculation experiments, cells were washed and resuspended in GVB-. Erythrocytes (5.3 X 108/mL) were incubated with A23187 (4 pmol/L) and calcium, or EDTA (3.3 mmol/L). To terminate vesiculation, EDTA (3.3 mmol/L) was added and the tubes were placed at 0°C.
Cells were then pelleted at 550g for 8 minutes and vesicles isolated from the supernatant by centrifugation at 30,OOOg for 15 minutes in a Beckman TL-100 (Beckman Instruments, Palo Alto, CA).
Erythrocytes (5.3 X 108/mL) were incubated with A23187 (4 pmol/L) at 37°C for 20 minutes. Calcium, containing a trace amount of 45Cazf, was then added. At various times, the medium was made 10 mmol/L in EDTA and spun through dibutyl phthalate. The cell pellet was analyzed for 45Ca2+ by 10% trichloracetic acid (TCA) precipitation and liquid scintillation counting. From the ratio of 45Ca2+ to cold calcium, the molecules of calcium per cell could be calculated.
All procedures for platelet isolation were performed at room temperature. Whole blood (collected in the presence of EDTA) was centrifuged at SOOg for 10 minutes. The plasma was then run over a Sepharose 2B column in Tyrode's-EDTA buffer. The void volume containing the platelets was collected. The platelets were pelleted by centrifugation at I ,400g for 15 minutes and resuspended in Tyrode's buffer. Platelets were used for an experiment the same day the blood was drawn with the exception of N.F. In this case, the patient's platelets were used 1 day after the blood was drawn. Blood from a normal individual was drawn at the same time as from the patient. The vesiculation of these normal platelets was the same as when this individual's platelets were used the same day they were drawn. Platelet concentration was estimated by Coulter Counter (Coulter Electronics, Hialeah, FL).
Platelets (0.6 to 2 X 108/mL) in Tyrode's buffer were incubated with A23187 (1.0 pmol/L) and calcium (1 mmol/L) at 37°C for 30 minutes, which was an endpoint for vesiculation. Platelets were also incubated in the presence of A23187 and 5 mmol/L EDTA as a negative control. Vesicles were isolated by a variation on the procedure of Fox et aLZ7 Platelets were pelleted at I ,400g for 15 minutes and the supernatant was subjected to centrifugation at 400,OOOg for 38 minutes to pellet the vesicles.
JY5 and JY25 were a generous gift from Dr Tim Springer (Harvard Medical School, Boston, MA). Cells were maintained in RPMI 1640 (GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS). For vesiculation experiments, cells (5 X 106/mL) were incubated in the dark with 20 pg/mL of a cationic membrane-associated fluorescent probe, I , 1'-dihexadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate [DiIC,,(3)] (Molecular Probes, Eugene, OR). Cells were incubated at 37°C for I hour in RPMI 1640 with 20 mmol/L HEPES, pH 7.4, supplemented with 10% FCS to allow incorporation ofthe probe into the plasma membrane.
Cells were washed, resuspended to 8 X 106/mL, and incubated in VBS either with or without A23187 (3 pmol/L) and calcium (1 mmol/ L) at 37°C. At various times the cells were pelleted at 4,500g for 1 minute. Vesicles were isolated on a 30% percoll gradient. After centrifugation, intact cells banded at a high density (> 1.07 g/mL), dead cells banded at a low density (d, <1.01 g/mL), and vesicles were found as a diffuse band at densities between 1.033 g/mL to 1.063 g/ mL. Vesicles were assayed by the florescence of DiICI6 (3) Plasma membranes of JY25 cells were isolated using a variation of the method of Diaz et al. 29 All manipulations were performed at 4°C. Cells were suspended to 2 X 107/mL in homogenization buffer containing 0.25 mol/L sucrose, 20 mmol/L HEPES, 0.5 mmol/L EGTA, 1 mmol/L phenymethylsulfonyl fluoride, 0. l mg/mL pepstatin, 0. l mg/mL soybean trypsin inhibitor, pH 7.0. Cells were disrupted by multiple passages through a double-ended 25-gauge needle (Bolab Products, Lake Havasu City, AZ). The homogenate was spun at 200g for IO minutes. The supernatant was then spun at 40,OOOg for I5 minutes. The pellet was resuspended in homogenization buffer and centrifuged over Percol1 (density, 1.045 g/mL) at 40,OOOg for 15 minutes. The plasma membranes were identified by activity of alkaline phosphodiesterase. DAF was quantitated on these membranes by a two-site radioimmunometric assay.30
Protein was assayed by fluorescamine using BSA as a ~tandard.~' Lipids from membranes were extracted by the technique of Rose and OaklandeP' and analyzed for phosphorus by the method of B a~t l e t t .~~ Five hundred microliters of a 50% suspension of erythrocytes in PBS was mixed with 2.5 mL ofisotonic 8 1% Percoll solution (Pharmacia) and the mixture was centrifuged at 30,OOOg for 15 minutes at 4°C.34 Erythrocytes were separated into several discrete bands and recovered in three fractions. The fraction consisting of cells from the middle of the gradient contained the majority of the cells (about 90%) of the total cells and was designated the "middle fraction." The cells obtained from the fractions above the middle fraction were designated the "top fraction." The cells below the middle fraction were designated "bottom fraction." Preliminary experiments demonstrated that the top fraction was enriched in reticulocytes sixfold relative to the bottom fraction. Mean corpuscular volume (MCV) of the various fractions was measured using a Coulter Stacker (Coulter).
In the case of normal controls, and multiple experiments using the same patient's cells, data are represented as the mean k standard deviation. Statistical analysis was performed using the Student's two-tailed t-test.
Plasma membrane isolation of JY25 cells. Protein and lipid measurements.
Separation of erythrocytes by density gradient centrifugation.
Statistical analysis.
RESULTS
Erythrocytes lacking GPI-linked proteins vesiculate less than normal erythrocytes. W e compared erythrocytes from normal individuals a n d C D W a n d DAF-negative erythrocytes from two PNH patients (S.B. and L.D.) with regard to their ability to vesiculate. I n the case of S.B., erythrocytes that were negative for CD59 a n d D A F were purified as outlined; these cells were totally negative for D A F and CD59 as measured by FACS analysis. Ten percent of the erythrocytes from L.D. were positive for D A F and CD59 by FACS analysis, and were used without purification. Erythrocytes were incubated with A23 187 and calcium for 1 hour, a time when vesiculation reached a endpoint. Controls consisted of erythrocytes incubated with A23187 and EDTA. The cells were pelleted and vesicles isolated from the supernatant. Vesicles were quantitated by measuring either protein (Fig 1) or lipid phosphate (Fig 2) . I The results demonstrate that GPI-negative erythrocytes from the PNH patients vesiculate significantly less than the normal erythrocytes when either vesicle lipid or vesicle protein is measured. In normal individuals, 12.2% of the total lipid phosphate is shed, whereas only 1 .O% of the protein is released into the supernatant. In patient L.D., 0.8% of the lipid and 0.23% of the protein is shed, whereas in patient S.B., 4.5% of the lipid and 0.49% of the protein is released as vesicles. The higher proportion of lipid than protein most likely reflects a much higher surface/volume ratio of the vesicles as compared with the intact erythrocytes.
We next wished to examine whether separating PNH and normal erythrocytes by density would effect the ability of the cells to vesiculate. For this experiment, we separated either normal erythrocytes or erythrocytes from patient L.D. on a percoll gradient before vesiculation. It has been previously shown that erythrocytes increase in density and decrease in volume as they age. 35 In addition, in erythrocytes from PNH patients, there is a progressive increase in GPI-positive cells as the erythrocytes age. As can be seen in Table 1 , all three fractions of L.D.'s erythrocytes show significantly less vesiculation than does the normal control. In addition, as the percentage of GPI-positive erythrocytes increase, the amount of vesiculation also increases. As this decreased ability to vesiculate is present in all fractions, including the youngest (lightest) erythrocytes, it indicates that the defect in vesiculation is an inherent defect in the PNH erythrocytes, not a consequence of prior in vivo vesiculation by the PNH erythrocytes.
Platelets that lack GPI-linked proteins vesiculate less than normal platelets in response to calcium loading. We compared vesiculation in platelets from 10 normal individuals with platelets from two PNH patients that were totally deficient in GPI-anchored proteins. Figure 3 shows that the PNH platelets vesiculate significantly less than the normal platelets when incubated with calcium and ionophore A23187.
A lymphoblastoid cell line that lacks GPI-linked molecules vesiculates less than the wild-type cells. The JY25 cell line expresses GPI-linked molecules, whereas JY5, a mutant of JY25, does not. In experiments not shown, we found that JY25 cells treated with A23187 and calcium produced lipid vesicles with the same density as vesicles produced by erythrocytes, and that these vesicles were enriched for DAF 10-fold relative to the untreated plasma membrane. The vesicles contain 3.26 X ng DAF/nmol lipid phosphate and the The normal and PNH erythrocytes were separated into three fractions, based on density using percoll gradient centrifugation as described in Materials and Methods. The top fraction is the least dense and the bottom fraction the most dense.
* Percent of erythrocytes that express CD59 and DAF.
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From plasma membrane contains 3.20 X ng DAF/nmol lipid phosphate. The amount of membrane that is released as vesicles is very small. Nevertheless, when we incorporated the fluorescent cationic membrane probe DiI in the plasma membrane of JY5 and JY25, and measured the fluorescence of the vesicles released into the supernatant, reproducible measurements of vesiculation were obtained. Figure 4 illustrates the results of a kinetic experiment in which we measured the percent of total incorporated DiI released as vesicles after incubation of the cells with ionophore for different periods of time. As shown, the wild-type JY25 cells release two to three times more vesicles than the mutant JY5 cells line. At the various time points, the proportion of dead JY5 and JY25 cells as measured by LDH release was not significantly different ( Table 2) .
We also removed GPI-linked proteins from the surface of JY25 cells in an attempt to obtain confirmatory evidence for the role of GPI in vesiculation. For this purpose, JY25 cells were treated with phosphatidylinositol-specific phospholipase C (PIPLC) from Bacillus thuringiensis (a generous gift from Dr Martin Low, Columbia University). This procedure led to the removal of 80% of DAF and CD59 from the JY25 cell surface. Nevertheless, the vesiculation experiments with the PIPLC-treated cells were inconclusive, because the combination of PIPLC and calcium ionophore treatments was toxic to the cells, leading to an unacceptable proportion of dead cells at the end of the incubation.
PNH GPI-negative erythrocytes vesiculate less than GPIpositive erythrocytes. Next, we wished to compare vesiculation in GPI-negative and GPI-positive erythrocytes from the same PNH patient. Although the negative cells could be purified using a very mild procedure (see Materials and Methods), unfortunately we could not isolate the positive cells without damaging them. For example, after treatment of the mixture with acidified serum to lyse the GPI-negative cells, the remaining cells showed excessive lysis when incubated with calcium and ionophore. For this reason, we could only compare vesiculation of normal erythrocytes (with unseparated erythrocytes from PNH patient S.B.) and of GPInegative erythrocytes from the same patient (negative for DAF and CD59 as determined by FACS analysis). This was performed on two separate occasions. About 70% of her cells were negative for DAF, CD59, and AChE, and about 30% were positive for these molecules. In one experiment, the "negative" cell population contained 4% GPI-positive cells.
Based on our previous observations, we expected that the cells that were negative for GPI-linked proteins would vesiculate less than red blood cells from a normal individual, and that the unseparated PNH cells would show intermediate The JY5 and JY25 cells in Fig 4 were assayed for cell death by the release of LDH into the supernatant Total releasable LDH was measured by incubation of the cells with mellitin The cells were preincubated with DilCls (3) and stimulated to vesiculate with 3 pmol/L A23187 and 1 mmol/L CaCI2 Background release was determined by using cells and CaCI2 without ionophore At various times, the cells were pelleted, the supernatant run over a percoll gradient, and the fractions corresponding to the vesicles were assayed for DilCla (3) fluorescence.
For levels of vesiculation. The results of this experiment (Fig 5 ) fully confirm these predictions. The unseparated and GPInegative erythrocytes from patient S.B. shed fewer vesicles than the normal cells, and the GPI-negative cells shed fewer vesicles than the unseparated cells. Furthermore, there is a linear relationship between the proportion of GPI-positive cells and the amounts of vesicles produced, suggesting strongly that the GPI-positive cells from S.B. vesiculate to the same extent as normal erythrocytes.
Next, we compared the ability of normal and PNH erythrocytes to vesiculate in the presence of various concentrations of calcium. The patient's (L.D.) erythrocytes were 90% negative for GPI-linked proteins and were used without further purification. In a preliminary experiment, we found that the kinetics of calcium uptake of the PNH and normal erythrocytes was identical and that a steady state was reached at 30 minutes. Normal and PNH erythrocytes were then incubated with 4 pmol/L A238 17 and various concentrations of CaCl, and vesiculation was measured after 60 minutes of incubation. To measure calcium uptake, a separate experiment was performed simultaneously in which the erythrocytes were incubated for 30 minutes with medium containing the same concentrations of ionophore and calcium, but including trace quantities of 45Ca2f. In Fig 6, we plotted the calculated intracellular Ca2+ concentrations versus quantities of vesicles released. As shown, the PNH erythrocytes show significantly less vesiculation than normal erythrocytes at equivalent amounts of calcium uptake. In addition, we observed that vesicle release was inhibited in both erythrocytes at high Ca2+
Calcium-dependence of the vesiculation process.
concentrations, a phenomenon observed by Allan and Thomas.36
DISC US S IO N
We studied here vesiculation of cells lacking GPI-linked proteins in response to an increase in intracellular calcium. When erythrocytes take up calcium, a number of biochemical events occur, including potassium efflux and consequent cell shrinkage (Gardos effe~t),~' breakdown of phosphatidylinositol4-phosphate and phosphatidylinositol 4,5-bisphosphate with a consequent increase in 1,2-diacylglycerol and phoshati id ate,^^ transglutaminase-catalyzed protein cross-linking,39 and proteolysis of some cytoskeletal protein^.^' Nevertheless, how these biochemical events lead to the release of erythrocyte vesicles is unknown.
Our main finding is that in three different GPI-deficient cell types, ie, erythrocytes and platelets from PNH patients, and in a mutant lymphoblastoid cell line, the defect was associated with a substantial decrease in the amount of plasma membrane vesicles released during incubation with ionophore A23187 and calcium. As documented in Fig 6 , the defect was observed at equivalent levels of intracellular Ca2+ accumulation in the GPI-positive and -negative cells.
It is also apparent that factors other than GPI-linked proteins play a role in membrane vesiculation. As can be seen in Figs 1 and 2 , even though 10% of the erythrocytes from L.D. are GPI-positive, they vesiculate less than the erythrocytes from S.B., which are negative for GPI-linked proteins. However, from the data in Table 1 For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
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from an individual are studied, as the percentage of cells that express GPI-linked proteins increases so does the vesiculation.
What is the explanation for the association between the two defects? They may not be causally related; nevertheless, some observations are compatible with the idea that the GPIanchored proteins participate in the process leading to membrane vesiculation. GPI-linked proteins are greatly enriched in the erythrocyte vesicles released from the Ca2+-ionophoreI7 or from complement-treated erythrocytes (Whitlow, Iida, and Marshall, unpublished observations). In addition, our data with the JY25 vesicles show an even more dramatic concentration of DAF relative to the plasma membrane. There are also indications that GPI-anchored molecules are associated with each other and with other membrane proteins, and that they participate in signaling intracellular events.
Crosslinking of GPI-linked proteins such as Ly-6, DAF, and CD59 can lead to the activation of T cells under appropriate cond i t i o n~.~~,~~~' In the case of Ly-6, this activation requires the presence of the glycolipid anchor.20 GPI-linked membrane proteins are associated with protein kinases, and cross-linking of GPI-linked molecules leads to phosphorylation of cellular proteins.23
Perhaps GPI-linked proteins rapidly accumulate in areas of Ca'+ influx, but this would necessitate specific signaling events, as well as mechanisms for the directional transport of the GPI proteins. Alternatively, domains of cellular membranes that are enriched in GPI-linked proteins may be preferentially vesiculated and shed. In support of this idea, lipid domains with compositions different from the bulk membrane have been shown in erythrocytes by fluorescence imaging micro~copy?~ but the partition of GPI-anchored proteins between these domains is not known. Differently from most other integral membrane proteins, those that are GPIlinked are poorly solubilized by nonionic detergents such as triton XIn polarized epithelial cells, GPI-anchored molecules are expressed exclusively on the apical surface?5 and may form protein-glycosphingolipid microdomains in the plasma m e m b~-a n e .~~,~~ Folate receptors, which are GPIlinked, are clustered in the The forces that lead to folate receptor clustering are not known; however, removal of cholesterol causes these clusters to disperse?8 On the basis of these reports, it is conceivable that the GPI-anchored proteins partition preferentially in plasma membrane domains enriched in certain membrane constituents such as cholesterol and glycosphigolipids. The functional consequences of this association are not clear, but perhaps it is important in membrane remodeling events such as vesiculation and some forms of endocytosis.
Studies on the Ca'+-dependent vesiculation of cells during attack by the terminal complement components C5b-9 also highlight the selectivity of the shedding p r o~e s s .~, '~,~~,~~ C9 is increased in concentration several fold in the vesicles relative to the remaining plasma membrane, indicating that the areas surrounding, or in close proximity to, the open channels are preferentially released as vesicles. Perhaps the assembly and/ or insertion of the membrane attack complex C5b-9 is not random and leads to channel formation more readily when it occurs in the putative GPI-enriched microdomains of the plasma membrane.
In short, we speculate that vesiculation may represent a facet of the normal process of turnover and repair of the plasma membrane in response to focal damage, and that domains of the membrane enriched in GPI-anchored molecules are preferentially released as vesicles. The triggering event may be Ca'+ influx at the site of disturbance of the lipid bilayer, and GPI may participate in the process. If this hypothesis is correct and there is a unique biochemical pathway leading to membrane vesiculation, our findings suggest that this pathway involves GPI and imply that cells from PNH patients should be more susceptible to destruction by membrane-perturbing agents other than complement.
An increase in intracellular calcium and very vigorous plasma membrane blebbing characterizes the initial stages of apoptosis and cell death. 50 In myocardial infarction, the myocytes within areas of ischemia are deficient in DAF.51 Perhaps the blebbing that occurs during cell death sheds GPIlinked proteins preferentially. It is also possible that preferential association of GPI-linked proteins and membrane internalization plays a role in receptor-mediated endocytosis by ~aveolae.~'
